PUBLICATIONS · 35607839
Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Haematol
- Publication date
- 2022 Sep
- First author
- Shichijo T
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Shichijo T
- type
- Author
- name
- Nosaka K
- type
- Author
- name
- Tatetsu H
- type
- Author
- name
- Higuchi Y
- type
- Author
- name
- Endo S
- type
- Author
- name
- Inoue Y
- type
- Author
- name
- Toyoda K
- type
- Author
- name
- Kikukawa Y
- type
- Author
- name
- Kawakita T
- type
- Author
- name
- Yasunaga JI
- type
- Author
- name
- Matsuoka M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Shichijo T
- type
- Author
- name
- Nosaka K
- type
- Author
- name
- Tatetsu H
- type
- Author
- name
- Higuchi Y
- type
- Author
- name
- Endo S
- type
- Author
- name
- Inoue Y
- type
- Author
- name
- Toyoda K
- type
- Author
- name
- Kikukawa Y
- type
- Author
- name
- Kawakita T
- type
- Author
- name
- Yasunaga JI
- type
- Author
- name
- Matsuoka M
- type
- Author
- bibliography ids
- nci-bib-bdd16087fcef6172a0743839
- book metadata
- content sha256
- 3412f106b1f87599f5f6717bef51278d3272f0d37dee6f059fbea29e9484872d
- document type
- citation
- dois
- 10.1111/bjh.18281
- electronic publication date
- display
- 2022 May 24
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35607839
- immutable id
- pubmed:35607839@3412f106b1f87599f5f6717bef51278d3272f0d37dee6f059fbea29e9484872d
- journal
- abbreviation
- Br J Haematol
- issn electronic
- 1365-2141
- issn print
- 0007-1048
- issue
- 6
- name
- British journal of haematology
- nlm unique id
- 0372544
- pages
- 983-987
- volume
- 198
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35607839
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- 122e3fe939e147ef7965a1bb37544be5d3160f8124ff9f9225c93e43b2b45449
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 Sep
- precision
- month
- year
- 2022
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle